Nan Li
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 5%
- Topics
- Medical Imaging Techniques and Applications (32 papers)Radiopharmaceutical Chemistry and Applications (26 papers)Peptidase Inhibition and Analysis (25 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Nan Li
135 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 124
- Oncology 1.0k
- Radiology, Nuclear Medicine and Imaging 805
- Pulmonary and Respiratory Medicine 614
- Molecular Biology 514
- Cancer Research 495
Countries citing papers authored by Nan Li
This map shows the geographic impact of Nan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Li more than expected).
Fields of papers citing papers by Nan Li
This network shows the impact of papers produced by Nan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Li. The network helps show where Nan Li may publish in the future.
Co-authorship network of co-authors of Nan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Nan Li. A scholar is included among the top collaborators of Nan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Li. Nan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 56 | |
| 13 | 1 | |
| 14 | 48 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 18 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | Prognostic role of thymidylate synthase expression in gastric cancer:A meta-analysis | 1 |
About Nan Li
Nan Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research, having authored 152 papers that have together received 2.6k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (32 papers), Radiopharmaceutical Chemistry and Applications (26 papers) and Peptidase Inhibition and Analysis (25 papers). The work is most often cited by research in Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (805 citations) and Cancer Research (495 citations). Nan Li has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Hua Zhu, Zhi Yang, Amrish Sharma, Shinya Neri, Wen Jiang, Yifan Wang, Weiye Deng, Steven H. Lin, Teli Liu and Xiaoxia Xu. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.